Effects of Ginkgo biloba on blood coagulation parameters: A systematic review of randomised clinical trials

Evidence-Based Integrative Medicine

Volumn 2, Issue 3, 2005, Pages 167-176

  Savović, Jelena ^a   Wider, Barbara ^b   Ernst, Edzard ^b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BILOBA; GINKGO BILOBA EXTRACT; SEREDRIN; WARFARIN;

BLOOD CLOTTING; DRUG SYNTHESIS; HUMAN; REVIEW; VASCULAR DISEASE;

EID: 33645514425     PISSN: 11762330     EISSN: 11762330     Source Type: Journal    
DOI: 10.2165/01197065-200502030-00007     Document Type: Review

References (29)

1. Rowin J, Lewis SL. Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion. Neurology 1996; 46 (6): 1775-6
2. Gilbert GJ. Ginkgo biloba [letter]. Neurology 1997; 48 (4): 1137
3. Vale S. Subarachnoid haemorrhage associated with Ginkgo biloba [letter]. Lancet 1998; 352 (9121): 36
4. Benjamin J, Muir T, Briggs K, et al. A case of cerebral haemorrhage: can Ginkgo biloba be implicated? Postgrad Med J 2001; 77 (904): 112-3
5. Fessenden J, Wittenborn W, Clarke L. Gingko biloba: a case report of herbal medicine and bleeding postoperatively from a laparoscopic cholecystectomy. Am Surg 2001; 67 (1): 33-5
6. Fong KCS, Kinnear PE. Retrobulbar haemorrhage associated with chronic Gingko biloba ingestion. Postgrad Med J 2003; 79 (935): 531-2
7. Rosenblatt M, Mindel J. Spontaneous hyphema associated with ingestion of Ginkgo biloba extract [letter]. N Engl J Med 1997; 336 (15): 1108
8. Matthews MK, Lewis SL, Rowin J. Association of Ginkgo biloba with intracerebral hemorrhage [multiple letters]. Neurology 1998; 50 (6): 1933-4
9. Meisel C, Johne A, Roots I. Fatal intracerebral mass bleeding associated with Ginkgo biloba and ibuprofen [letter]. Atherosclerosis 2003; 167 (2): 367
10. Ernst E, Canter PH, Thompson-Coon J. Does Ginkgo biloba increase the risk of bleeding? A systematic review of case reports. Perfusion 2005; 18 (2): 52-6
11. Guinot P, Braquet P, Duchier J, et al. Inhibition of PAF-acether induced weal and flare reaction in man by a specific PAF antagonist. Prostaglandins 1986; 32 (1): 160-3
12. Braquet P, Hosford D. Ethnopharmacology and the development of natural PAF antagonists as therapeutic agents. J Ethnopharmacol 1991; 32 (1-3): 135-9
13. Chung KF, Dent G, McCusker M, et al. Effect of a ginkgolide mixture (BN 52063) in antagonising skin and platelet responses to platelet activating factor in man. Lancet 1987; I (8527): 248-51
14. Braquet P. Cedemin, a Ginkgo biloba extract, should not be considered as a PAF antagonist [letter]. Am J Gastroenterol 1993; 88 (12): 2138
15. Morris CA, Avorn J. Internet marketing of herbal products. JAMA 2003; 290 (11): 1505-9
16. Morgenstern C, Biermann E. The efficacy of Ginkgo special extract EGb 761 in patients with tinnitus. Int J Clin Pharmacol Ther 2002; 40 (5): 188-97
17. Schneider LS, DeKosky ST, Farlow MR, et al. A randomized, double-blind, placebo-controlled trial of two doses of Ginkgo biloba extract in dementia of the Alzheimer's type. Curr Alzheimer Res 2005; 2 (5): 541-51
18. Kanowski S, Herrmann WM, Stephan K, et al. Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia. Pharmacopsychiatry 1996; 29 (2): 47-56
19. Morgenstern C, Biermann E. Ginkgo-Spezialextrakt EGb 761 in der Behandlung des Tinnitus aurium. Ergebnisse einer randomisierten, doppelblinden, plazebokontrollierten Studie. Fortschr Med Orig 1997; 115 (4): 7-11
20. Taillandier J, Ammar A, Rabourdin JP, et al. Traitement des troubles du viellissement cérébral par l'extrait de Ginkgo biloba. Etude longitudinale, multicentrique à double insu face au placebo. Presse Méd 1986; 15 (31): 1583-7
21. Thomson GJL, Vohra RK, Carr MH, et al. A clinical-trial of Ginkgo-biloba extract in patients with intermittent claudication. Int Angiol 1990; 9 (2): 75-8
22. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17 (1): 1-12
23. Bal Dit Sollier C, Caplain H, Drouet L. No alteration in platelet function or coagulation induced by EGb761 in a controlled study. Clin Lab Haematol 2003; 25 (4): 251-3
24. Köhler S, Funk P, Kieser M. Influence of a 7-day treatment with Ginkgo biloba special extract EGb 761 on bleeding time and coagulation: a randomized, placebo-controlled, double-blind study in healthy volunteers. Blood Coagul Fibrinolysis 2004; 15 (4): 303-9
25. Hofferberth B. Simultanerfassung elektrophysiologischer, psychometricher und rheologischer Parameter bei Patienten mit hirnorganischem Psychosyndrom und erhoehtem Gefaessrisiko - Eine Placebo-kontrollierte Doppelblind-studie mit Ginkgo biloba-Extrakt EGb 76. In: Stodtmeister R, Pillunat L, editors. Mikrozirkulation in Gehirn und Sinnesorganen. Stuttgart: Enke, 1991
26. Mancini M, Agozzino B, Bompani R. Effetti clinico-terapeutici dell'estrato di Ginkgo biloba (Egb) in confronto a placebo, nel trattamento di pazienti affetti da demeza psicorganica senile su base arteriosclerotica. Gazz Med Ital Arch Sci Med 1993; 152 (3): 69-80
27. Muir AH, Robb R, McLaren M, et al. The use of Ginkgo biloba in Raynaud's disease: a double-blind placebo-controlled trial. Vasc Med 2002; 7 (4): 265-7
28. Engelsen J, Nielsen JD, Winther K. Effect of coenzyme Q10 and Ginkgo biloba on warfarin dosage in stable, long-term warfarin treated outpatients: a randomised, double blind, placebo-crossover trial. Thromb Haemost 2002; 87 (6): 1075-6
29. Engelsen J, Nielsen JD, Hansen KF. Effekten af Coenzym Q10 og Ginkgo biloba pa warfarindosis hos patienter i laengerevarende warfarinbehandling. Et randomisert, dobbelblindt, placebokontrolleret overkrydsningsforsog. Ugeskr Laeger 2003; 165 (18): 1868-71